| 股票 | 富途行业 | PE | PB | 股息率 | 分红率 | 毛利率 | ROE | 固定资产 | 负债率 | OCF/市值 | 营收增速 | 利润增速 | 近60日 | YTD | 近一年 | 距52周高 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aytu BioPharma AYTU | 专业与通用药品制造商 | -0.5 | 0.68 | 0.0% | — | 69% | -58% | 1% | 85% | 7.1% | +2% | +14% | -1% | -15% | -3% | 72% | 0 |
| Akebia Therapeutics AKBA | 专业与通用药品制造商 | -8.9 | 10.83 | 0.0% | — | 83% | 0% | 1% | 91% | 15.4% | +48% | +92% | +12% | -40% | -69% | 30% | 3 |
| Bausch Health BHC | 专业与通用药品制造商 | -2.2 | -1.39 | 0.0% | — | 71% | 0% | 8% | 99% | 73.4% | +7% | +267% | +27% | -6% | -10% | 82% | 25 |
| 普雷斯蒂奇 PBH | 专业与通用药品制造商 | 14.6 | 1.29 | 0.0% | 0% | 55% | 10% | 3% | 46% | 10.1% | -4% | -11% | +6% | -15% | -21% | 74% | 25 |
| BioCryst制药 BCRX | 专业与通用药品制造商 | -7.1 | -5.60 | 0.0% | — | 98% | 0% | 3% | 123% | 14.8% | +94% | +397% | +22% | +28% | +22% | 89% | 25 |
| 武田制药 TAK | 专业与通用药品制造商 | -55.1 | 1.21 | 3.2% | — | 65% | -2% | 12% | 52% | 11.1% | -7% | -233% | +18% | +20% | +26% | 98% | 589 |
点表头排序。市值单位亿美元;财务为最近年报(futu 筛选器);分红率 = 股息率 × PE;OCF/市值 = 经营现金流 ÷ 市值(无 FCF);距52周高 = 现价 / 52 周最高。